Biotech Industry News

A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

france24.com - Hollywood's fresh take on tech titans: from heroes to villains
Hollywood's fresh take on tech titans: from heroes to villains
FRANCE 24 –

From convicted biotech fraudster Elizabeth Holmes to tech giants Elon Musk, Mark Zuckerberg and Sam Altman, the marquees are dominated by the headline makers who have wowed the world -- and the markets -- with promises of innovation. 'These figures…

fool.com - Rick Orford - Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline
Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline
The Motley Fool –

Moderna isn't the only mRNA biotech stock that could deliver big gains for investors. BioNTech (BNTX -2.76%) has billions in cash on its books and a cancer treatment pipeline that could transform it from a COVID-19 vaccine maker into a major force…

globaltimes.cn - Xinhua - China Magnet' attracts growing interest from global talent
China Magnet' attracts growing interest from global talent
Global Times –

A foreign tourist tries on hair ornaments at a mall in Shanghai, east China, May 5, 2026. (Xinhua/Chen Haoming) For 33-year-old Federico Flamenco, a Salvadoran engineer working in China's robotics industry, a once-distant career dream has become a…

seekingalpha.com - Bret Jensen - Housing Is Heading Toward A 'Deep Freeze
Housing Is Heading Toward A 'Deep Freeze
Seeking Alpha –

U.S. residential real estate is heading towards a 'deep freeze,' with existing home sales at 1995 lows and inventory at multi-year highs. Surging mortgage rates, now around 7.5%, have dramatically increased monthly payments, deterring buyers and…

fool.com - Prosper Junior Bakiny - Forget Eylea: Regeneron's Real Value May Be Hiding in Its Dupixent Profit Share
Forget Eylea: Regeneron's Real Value May Be Hiding in Its Dupixent Profit Share
The Motley Fool –

Regeneron Pharmaceuticals (REGN -0.70%) has underperformed broader equities over the past two years. Perhaps the biggest reason for that is the company's declining sales of Eylea, a medicine that treats several eye-related conditions. Regeneron has…

koreaherald.com - Lee Seung-ku - [World Class] HUFS bets on Songdo, AI to redefine what a global university can do
[World Class] HUFS bets on Songdo, AI to redefine what a global university can do
The Korea Herald –

President Kang Kee-hoon says new Songdo campus will serve as gateway before international students move into majors at Seoul and Yongin campuses Behind each university's global ambitions are choices about what to preserve, what to develop and where…

elle.com - Starr Bowenbank - Elizabeth Holmes's Partner Billy Evans Says She 'Looks Insane' in 'You Can See Everything'
Elizabeth Holmes's Partner Billy Evans Says She 'Looks Insane' in 'You Can See Everything'
ELLE –

This story contains spoilers for You Can See Everything. When Nathan Fielder asked Elizabeth Holmes to document the days leading up to her serving her prison sentence for his new A24 documentary, You Can See Everything, the proposition meant that…

today.com - The Shocking 'You Can See Everything' Twist: Wait, Who Shows Up in the Elizabeth Holmes Documentary?
The Shocking 'You Can See Everything' Twist: Wait, Who Shows Up in the Elizabeth Holmes Documentary?
TODAY –

Spoilers ahead for “You Can See Everything,” the documentary about Elizabeth Holmes. Thirty-four days before she was set to enter prison in 2023, Elizabeth Holmes let a film crew into her home. “You Can See Everything,”…

fool.com - Keith Speights - Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle
Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle
The Motley Fool –

Not all high-yield dividend stocks are created equal. Some are genuine income compounders, while others are traps. And the current environment, with interest rates on the rise, makes it more difficult to differentiate the good from the bad. AbbVie…

marketbeat.com - 9,461 Shares in Danaher Corporation $DHR Bought by Eagle Strategies LLC
9,461 Shares in Danaher Corporation $DHR Bought by Eagle Strategies LLC
MarketBeat –

Eagle Strategies LLC bought a new position in Danaher Corporation (NYSE:DHR - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 9,461 shares of the conglomerate's stock, valued…

marketbeat.com - Larimar Therapeutics (NASDAQ:LRMR) Shares Down 0.3% - Should You Sell?
Larimar Therapeutics (NASDAQ:LRMR) Shares Down 0.3% - Should You Sell?
MarketBeat –

Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report)'s share price dropped 0.3% during mid-day trading on Friday. The company traded as low as $1.92 and last traded at $1.9850. Approximately 1,691,963 shares changed hands during trading, a…

marketbeat.com - Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Moved Up to 'Buy' by Wall Street Zen
Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Moved Up to 'Buy' by Wall Street Zen
MarketBeat –

Vertex Pharmaceuticals (NASDAQ:VRTX - Get Free Report) was upgraded by analysts at Wall Street Zen from a 'hold' rating to a 'buy' rating in a report released on Saturday, Wall Street Zen reports. Vertex's Crinetics Deal Balances Growth with…

marketbeat.com - Cyndeo Wealth Partners LLC Acquires 273,158 Shares of Axon Enterprise, Inc $AXON
Cyndeo Wealth Partners LLC Acquires 273,158 Shares of Axon Enterprise, Inc $AXON
MarketBeat –

Cyndeo Wealth Partners LLC acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional…

thehindubusinessline.com - KS Badri Narayanan - Q2 Results Highlights, 17th Oct: HDFC Bank, ICICI Bank, Axis Bank, IDBI Bank, Central Bank of India post profit growth; YES Bank flags AT-1 bond ruling impact
Q2 Results Highlights, 17th Oct: HDFC Bank, ICICI Bank, Axis Bank, IDBI Bank, Central Bank of India post profit growth; YES Bank flags AT-1 bond ruling impact
BusinessLine –

Q2 Results Highlights, 17th October 2026: Find all the latest Q2 results 2026 updates AXIS Bank, Bajaj Healthcare, Central Bank of India, Cupid Breweries And Distilleries, Gagan Gases, HDFC Bank, Hemo Organic, ICICI Bank, Indo Cotspin, IDBI Bank…

marketbeat.com - Recursion Pharmaceuticals (NASDAQ:RXRX) Upgraded at Wall Street Zen
Recursion Pharmaceuticals (NASDAQ:RXRX) Upgraded at Wall Street Zen
MarketBeat –

Recursion Pharmaceuticals (NASDAQ:RXRX - Get Free Report) was upgraded by Wall Street Zen from a 'strong sell' rating to a 'sell' rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports. 2 Reasons Absci…

Receive a Daily briefing on Biotech Industry News

Get Started